These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 6884638

  • 1. [Rational use of diuretics in hepatic cirrhosis].
    Vagge R, Cavatorta F, Queirolo C.
    G Clin Med; 1983; 64(3-4):116-23. PubMed ID: 6884638
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical evaluation of the use of diuretics in the ascitic phase of hepatic cirrhosis].
    Castagnolo B, De Colibus V, Napolitano L, Aliperta A, Caldarelli G, Abignente F.
    Clin Ter; 1977 Dec 31; 83(6):625-9. PubMed ID: 343976
    [No Abstract] [Full Text] [Related]

  • 3. The impact of diuretics on chronic liver disease.
    Steigmann F, Mejicano R.
    Am J Gastroenterol; 1969 Jul 31; 52(1):37-44. PubMed ID: 5796683
    [No Abstract] [Full Text] [Related]

  • 4. Use of diuretics in the treatment of cirrhotic ascites.
    Boyer TD, Warnock DG.
    Gastroenterology; 1983 May 31; 84(5 Pt 1):1051-5. PubMed ID: 6832557
    [No Abstract] [Full Text] [Related]

  • 5. [Prolonged treatment of ascitic cirrhosis by the combination of a saldiuretic and a spironolactone].
    Tolot F, Dechavannes M, Fiere D.
    Lyon Med; 1966 Jan 02; 215(1):29-35. PubMed ID: 5904663
    [No Abstract] [Full Text] [Related]

  • 6. [Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].
    Grassi V, Porcellati C, Corea L, Todisco T.
    Minerva Nefrol; 1968 Jan 02; 15(4):258-60. PubMed ID: 5745815
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of azosemide and furosemide in ascitic patients without and during administration of spironolactone.
    Radó JP, Molnár Z, Hartai A, Gercsák G.
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov 02; 20(11):532-7. PubMed ID: 7174156
    [Abstract] [Full Text] [Related]

  • 8. [Comparative study of diuretic drugs used in cirrhotic and ascitic patients].
    Lennhoff M, Duhalt R, Peña JC.
    Rev Invest Clin; 1968 Nov 02; 20(2):165-80. PubMed ID: 5721631
    [No Abstract] [Full Text] [Related]

  • 9. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
    Lenaerts A, Codden T, Meunier JC, Henry JP, Ligny G.
    Hepatology; 2006 Oct 02; 44(4):844-9. PubMed ID: 17006921
    [Abstract] [Full Text] [Related]

  • 10. [Influence of diuretics on the survival of 180 patients with cirrhosis of the liver and ascites].
    Robert M, Portmann B.
    Schweiz Med Wochenschr; 1969 Feb 08; 99(6):178-82. PubMed ID: 5781367
    [No Abstract] [Full Text] [Related]

  • 11. [Modern diuretics in the treatment of ascites caused by hepatic cirrhosis].
    Buligescu L, Candiori R.
    Med Interna (Bucur); 1970 May 08; 22(5):573-92. PubMed ID: 5426383
    [No Abstract] [Full Text] [Related]

  • 12. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
    Lenaerts A, Codden T, Henry JP, Van Cauter J, Meunier JC, Ligny G.
    Gastroenterol Clin Biol; 2001 Mar 08; 25(3):268-72. PubMed ID: 11395674
    [Abstract] [Full Text] [Related]

  • 13. [Modern diuretic therapy in chronic liver diseases].
    Schnack H.
    Wien Med Wochenschr; 1965 Sep 25; 115(39):796-801. PubMed ID: 5325222
    [No Abstract] [Full Text] [Related]

  • 14. [The behavior of uricemia during treatment with spironolactone and with other diuretics].
    Bufalari A, Meloni G.
    Minerva Med; 1967 Nov 07; 58(89):3815-22. PubMed ID: 6074933
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of ascites in hepatic cirrhosis].
    Arroyo JL, Bueno J, Rivero A, Lucas I, Ortiz de Landazuri E.
    Rev Esp Enferm Apar Dig; 1966 Nov 07; 25(9):1021-46. PubMed ID: 5997895
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts].
    Vesin P.
    Schweiz Med Wochenschr; 1971 Mar 20; 101(11):398-401. PubMed ID: 5558553
    [No Abstract] [Full Text] [Related]

  • 17. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G, Economou M, Fotopoulos A, Bokharhii JA, Katsaraki A, Tsianos EV.
    Nephrol Dial Transplant; 2005 Aug 20; 20(8):1623-9. PubMed ID: 15886218
    [Abstract] [Full Text] [Related]

  • 18. [Contribution to the study of the treatment of the ascitic syndrome of cirrhosis by the combination of spironolactone and sulfonamide diuretic. Initial therapy and supportive therapy. Apropos of 55 cases].
    Fraisse H, Perret M, Etaix JP.
    J Med Lyon; 1967 Feb 05; 48(114):173-83. PubMed ID: 5600100
    [No Abstract] [Full Text] [Related]

  • 19. Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study.
    Thuluvath PJ, Maheshwari A, Wong F, Yoo HW, Schrier RW, Parikh C, Steare S, Korula J.
    Aliment Pharmacol Ther; 2006 Sep 15; 24(6):973-82. PubMed ID: 16948809
    [Abstract] [Full Text] [Related]

  • 20. Spironolactone and frusemide in cirrhosis with ascites.
    Sadikali F.
    Br J Clin Pract; 1973 Jun 15; 27(6):222-4. PubMed ID: 4582147
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.